Table 4.
Genotype | Cav-1+/+ | Cav-1+/− | Cav-1−/− |
---|---|---|---|
Number of mice | 25 | 43 | 9* |
Age at tumor onset (days ± SEM) | 404 ± 24 | 343 ± 15 | 303 ± 15 |
Age at harvest (days ± SEM) | 469 ± 26 | 407 ± 16 | 354 ± 17 |
Tumor growth (days ± SEM) | 65 ± 5 | 64 ± 4 | 51 ± 6 |
Median survival (days) | 454 | 384 | 361 |
Incidence of visible lung mets (%) | 28 | 23 | 20 |
Significance differences in tumor onset time were assessed by the Gehan-Breslow-Wilcoxon test. P = 0.002 for the difference between Cav+/+ and Cav−/− mice and P = 0.026 for the difference between Cav+/+ and Cav+/− mice.
Only 9 of the original 15 mice were available for final analysis due to losses from non-tumor related causes during the experiment.